Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 13 | 2021 | 466 | 2.130 |
Why?
|
| Volatile Organic Compounds | 2 | 2023 | 8 | 0.880 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 36 | 0.850 |
Why?
|
| Faculty, Nursing | 1 | 2023 | 44 | 0.820 |
Why?
|
| Parents | 3 | 2021 | 113 | 0.750 |
Why?
|
| Epidemics | 1 | 2021 | 2 | 0.730 |
Why?
|
| Electronic Nose | 2 | 2023 | 3 | 0.720 |
Why?
|
| Breath Tests | 2 | 2023 | 10 | 0.720 |
Why?
|
| Nurse's Role | 2 | 2021 | 59 | 0.720 |
Why?
|
| Patient Care | 1 | 2021 | 30 | 0.710 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2019 | 109 | 0.710 |
Why?
|
| Stress, Psychological | 3 | 2019 | 235 | 0.690 |
Why?
|
| Publications | 1 | 2020 | 16 | 0.670 |
Why?
|
| Biosensing Techniques | 1 | 2020 | 11 | 0.670 |
Why?
|
| Bayes Theorem | 1 | 2020 | 42 | 0.660 |
Why?
|
| Statistics as Topic | 1 | 2020 | 105 | 0.660 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 37 | 0.640 |
Why?
|
| Parenting | 1 | 2019 | 72 | 0.610 |
Why?
|
| Immunosenescence | 1 | 2018 | 3 | 0.600 |
Why?
|
| Fish Oils | 1 | 2018 | 4 | 0.600 |
Why?
|
| Caregivers | 1 | 2019 | 197 | 0.540 |
Why?
|
| Cytokines | 1 | 2018 | 222 | 0.540 |
Why?
|
| Humans | 35 | 2023 | 27072 | 0.530 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2021 | 61 | 0.520 |
Why?
|
| Inflammation | 1 | 2018 | 272 | 0.520 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 501 | 0.480 |
Why?
|
| HIV Wasting Syndrome | 2 | 2013 | 4 | 0.460 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 552 | 0.460 |
Why?
|
| Anticholesteremic Agents | 2 | 2011 | 14 | 0.410 |
Why?
|
| Complementary Therapies | 1 | 2012 | 7 | 0.390 |
Why?
|
| Education, Nursing, Graduate | 1 | 2012 | 43 | 0.370 |
Why?
|
| Fatty Alcohols | 1 | 2011 | 6 | 0.360 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 16 | 0.360 |
Why?
|
| Mannans | 2 | 2013 | 14 | 0.360 |
Why?
|
| Dyslipidemias | 1 | 2011 | 16 | 0.360 |
Why?
|
| Obesity | 3 | 2013 | 311 | 0.350 |
Why?
|
| Weight Loss | 3 | 2013 | 127 | 0.340 |
Why?
|
| Anesthesia | 2 | 2021 | 29 | 0.290 |
Why?
|
| Dietary Supplements | 5 | 2018 | 66 | 0.290 |
Why?
|
| Hyperlipidemias | 2 | 2004 | 18 | 0.280 |
Why?
|
| Double-Blind Method | 4 | 2018 | 406 | 0.280 |
Why?
|
| Anesthesia, General | 2 | 2019 | 25 | 0.270 |
Why?
|
| Anti-Obesity Agents | 1 | 2005 | 4 | 0.250 |
Why?
|
| Child, Preschool | 4 | 2021 | 641 | 0.250 |
Why?
|
| Dietary Fiber | 1 | 2005 | 27 | 0.250 |
Why?
|
| Body Weight | 1 | 2005 | 134 | 0.240 |
Why?
|
| Female | 14 | 2023 | 15212 | 0.230 |
Why?
|
| Lipids | 1 | 2004 | 51 | 0.230 |
Why?
|
| Insulin Resistance | 1 | 2004 | 50 | 0.230 |
Why?
|
| Enteral Nutrition | 2 | 2004 | 66 | 0.220 |
Why?
|
| Middle Aged | 8 | 2019 | 8923 | 0.220 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 68 | 0.220 |
Why?
|
| Nonlinear Dynamics | 1 | 2023 | 12 | 0.210 |
Why?
|
| United States | 4 | 2019 | 2035 | 0.210 |
Why?
|
| Adult | 10 | 2019 | 7831 | 0.210 |
Why?
|
| Hospitalization | 2 | 2016 | 300 | 0.210 |
Why?
|
| Male | 11 | 2019 | 14772 | 0.200 |
Why?
|
| Arginine | 1 | 2002 | 17 | 0.200 |
Why?
|
| Immunity | 1 | 2002 | 15 | 0.200 |
Why?
|
| Advance Care Planning | 1 | 2022 | 11 | 0.200 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 482 | 0.200 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2002 | 41 | 0.190 |
Why?
|
| Racism | 1 | 2022 | 31 | 0.190 |
Why?
|
| Adolescent | 4 | 2019 | 2172 | 0.190 |
Why?
|
| Nursing Services | 1 | 2021 | 1 | 0.180 |
Why?
|
| Child | 3 | 2021 | 1295 | 0.180 |
Why?
|
| Nursing Research | 1 | 2021 | 33 | 0.180 |
Why?
|
| Exercise | 3 | 2021 | 450 | 0.180 |
Why?
|
| Patient Satisfaction | 2 | 2014 | 317 | 0.180 |
Why?
|
| Health Literacy | 1 | 2022 | 108 | 0.170 |
Why?
|
| Organizational Innovation | 1 | 2020 | 12 | 0.170 |
Why?
|
| Exhalation | 1 | 2020 | 3 | 0.170 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 231 | 0.170 |
Why?
|
| Physical Fitness | 1 | 2020 | 51 | 0.170 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 25 | 0.160 |
Why?
|
| Cholesterol, HDL | 3 | 2011 | 26 | 0.160 |
Why?
|
| Cholesterol, LDL | 3 | 2011 | 29 | 0.160 |
Why?
|
| Triglycerides | 3 | 2011 | 61 | 0.160 |
Why?
|
| Decision Making | 1 | 2021 | 223 | 0.160 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2018 | 21 | 0.150 |
Why?
|
| Midwestern United States | 1 | 2018 | 48 | 0.150 |
Why?
|
| Breast Feeding | 1 | 2019 | 170 | 0.140 |
Why?
|
| Police | 1 | 2016 | 2 | 0.130 |
Why?
|
| Prisoners | 1 | 2016 | 11 | 0.130 |
Why?
|
| Milk, Human | 1 | 2019 | 201 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 891 | 0.130 |
Why?
|
| Depression | 1 | 2020 | 444 | 0.130 |
Why?
|
| Cognition | 2 | 2021 | 1339 | 0.120 |
Why?
|
| Biomarkers | 1 | 2018 | 562 | 0.120 |
Why?
|
| Treatment Failure | 2 | 2013 | 158 | 0.110 |
Why?
|
| Perioperative Nursing | 1 | 2014 | 3 | 0.110 |
Why?
|
| Cathartics | 1 | 2013 | 6 | 0.110 |
Why?
|
| Prevalence | 2 | 2013 | 443 | 0.110 |
Why?
|
| Nurse-Patient Relations | 1 | 2014 | 44 | 0.110 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 44 | 0.110 |
Why?
|
| Military Personnel | 1 | 2014 | 39 | 0.110 |
Why?
|
| Models, Statistical | 1 | 2014 | 127 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 879 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2019 | 985 | 0.100 |
Why?
|
| Body Composition | 3 | 2013 | 68 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2011 | 64 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2017 | 420 | 0.090 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2009 | 1 | 0.080 |
Why?
|
| Treatment Outcome | 6 | 2009 | 3485 | 0.070 |
Why?
|
| Infant | 2 | 2019 | 564 | 0.070 |
Why?
|
| Cholesterol | 2 | 2004 | 64 | 0.070 |
Why?
|
| Quality of Life | 2 | 2022 | 629 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 333 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2004 | 18 | 0.060 |
Why?
|
| Sample Size | 1 | 2004 | 18 | 0.060 |
Why?
|
| Fasting | 1 | 2004 | 21 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 216 | 0.060 |
Why?
|
| Pneumonia, Aspiration | 1 | 2004 | 8 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2004 | 38 | 0.060 |
Why?
|
| Insulin | 1 | 2004 | 89 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2004 | 104 | 0.060 |
Why?
|
| Hot Flashes | 1 | 2003 | 11 | 0.050 |
Why?
|
| Plant Preparations | 1 | 2003 | 7 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2003 | 11 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2004 | 116 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2004 | 115 | 0.050 |
Why?
|
| Social Problems | 1 | 2023 | 7 | 0.050 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 175 | 0.050 |
Why?
|
| Food Technology | 1 | 2002 | 1 | 0.050 |
Why?
|
| Food, Genetically Modified | 1 | 2002 | 1 | 0.050 |
Why?
|
| Low Back Pain | 1 | 2004 | 130 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2002 | 45 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 81 | 0.050 |
Why?
|
| Placebos | 1 | 2002 | 65 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 37 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 43 | 0.050 |
Why?
|
| HIV | 1 | 2002 | 39 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 261 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2004 | 483 | 0.050 |
Why?
|
| Food, Formulated | 1 | 2002 | 5 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2022 | 75 | 0.050 |
Why?
|
| Grounded Theory | 1 | 2021 | 4 | 0.050 |
Why?
|
| Health Personnel | 1 | 2022 | 94 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 88 | 0.050 |
Why?
|
| Aged | 4 | 2021 | 8997 | 0.050 |
Why?
|
| Biological Products | 1 | 2002 | 43 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2021 | 114 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 223 | 0.040 |
Why?
|
| Nurse Anesthetists | 1 | 2019 | 2 | 0.040 |
Why?
|
| Acute Disease | 1 | 2019 | 176 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2013 | 458 | 0.040 |
Why?
|
| Mothers | 1 | 2021 | 186 | 0.040 |
Why?
|
| Dementia | 1 | 2004 | 560 | 0.040 |
Why?
|
| Animals | 1 | 2005 | 3642 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 17 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 642 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 1368 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 14 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 759 | 0.030 |
Why?
|
| Prisons | 1 | 2016 | 8 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 204 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 220 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 474 | 0.030 |
Why?
|
| Hospitals, Military | 1 | 2014 | 1 | 0.030 |
Why?
|
| Empathy | 1 | 2014 | 39 | 0.030 |
Why?
|
| Disease Progression | 2 | 2009 | 673 | 0.030 |
Why?
|
| Communication | 1 | 2014 | 104 | 0.030 |
Why?
|
| Safety | 2 | 2002 | 37 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2009 | 12 | 0.020 |
Why?
|
| Morbidity | 1 | 2009 | 54 | 0.020 |
Why?
|
| Energy Intake | 1 | 2009 | 83 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2009 | 72 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2009 | 58 | 0.020 |
Why?
|
| Life Style | 1 | 2009 | 186 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 1994 | 0.020 |
Why?
|
| Injections, Epidural | 1 | 2004 | 15 | 0.010 |
Why?
|
| Angelica sinensis | 1 | 2003 | 1 | 0.010 |
Why?
|
| Cimicifuga | 1 | 2003 | 1 | 0.010 |
Why?
|
| Soy Foods | 1 | 2003 | 1 | 0.010 |
Why?
|
| Isoflavones | 1 | 2003 | 2 | 0.010 |
Why?
|
| Phytoestrogens | 1 | 2003 | 4 | 0.010 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2003 | 5 | 0.010 |
Why?
|
| Vitamin E | 1 | 2003 | 44 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 131 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2002 | 20 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2002 | 26 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2002 | 53 | 0.010 |
Why?
|
| Viral Load | 1 | 2002 | 69 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 125 | 0.010 |
Why?
|